Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
出版年份 2013 全文链接
标题
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 106, Issue 1, Pages -
出版商
Oxford University Press (OUP)
发表日期
2013-12-04
DOI
10.1093/jnci/djt347
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pancreatic Adenocarcinoma, Version 2.2012
- (2017) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma
- (2012) Sarah B. Fisher et al. CANCER
- Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical Approaches
- (2012) David A. Tuveson et al. CELL
- Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma
- (2012) Raphaël Maréchal et al. GASTROENTEROLOGY
- Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine
- (2012) Natsuko Kawada et al. Journal of Hepato-Biliary-Pancreatic Sciences
- New biomarkers and targets in pancreatic cancer and their application to treatment
- (2012) Eithne Costello et al. Nature Reviews Gastroenterology & Hepatology
- Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in patients with pancreatic carcinoma treated with adjuvant gemcitabine-based chemotherapy after operative resection
- (2012) Naoya Nakagawa et al. SURGERY
- New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel
- (2011) J.- L. Van Laethem et al. ANNALS OF ONCOLOGY
- Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer
- (2011) Richard Kim et al. CANCER
- Nucleobase Transport by Human Equilibrative Nucleoside Transporter 1 (hENT1)
- (2011) Sylvia Y. M. Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy
- (2011) Yasuhiro Murata et al. Journal of Hepato-Biliary-Pancreatic Sciences
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Strategies in Pancreatic Cancer: Emerging Epidemiologic and Therapeutic Concepts
- (2010) D. Li et al. CLINICAL CANCER RESEARCH
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials
- (2009) Marcella Sarzotti-Kelsoe et al. PLOS MEDICINE
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
- (2008) James J. Farrell et al. GASTROENTEROLOGY
- Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma
- (2008) William F. Regine et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adjuvant Chemoradiation for Pancreatic Cancer: Few Good Data, Much Debate
- (2008) Renee Twombly JNCI-Journal of the National Cancer Institute
- Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins
- (2008) J. D. Young et al. XENOBIOTICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More